Pharmacognosy Magazine

: 2011  |  Volume : 7  |  Issue : 28  |  Page : 314--319

Antioxidative effects of cinnamomi cortex: A potential role of iNOS and COX-II

Jin-Won Chung, Jeong-Jun Kim, Sung-Jin Kim 
 Department of Pharmacology and Toxicology, School of Dentistry, Kyung Hee University, Seoul 130-701, Korea

Correspondence Address:
Sung-Jin Kim
Department of Pharmacology and Toxicology, School of Dentistry, Kyung Hee University, Seoul 130-701


Background: Cinnamomi cortex has wide varieties of pharmacological actions such as anti-inflammatory action, anti-platelet aggregation, and improving blood circulation. In this study, we tested to determine whether the Cinnamomi cortex extract has antioxidant activities. Materials and Methods: Antioxidative actions were explored by measuring free radical scavenging activity, NO levels, and reducing power. The mechanism of antioxidative action of Cinnamomi cortex was determined by measuring iNOS and COX-II expression in lipopolysaccharide (LPS) stimulated Raw cells. Results: Seventy percent methanolic extract of Cinnamomi cortex exerted significant 1,1­diphenyl-­2-­picrylhydrazyl (DPPH) free radicals and NO scavenging activities in a dose-dependent manner. More strikingly, the Cinnamomi cortex extract exerted dramatic reducing power activity (13-fold over control). Production of iNOS induced by LPS was significantly inhibited by the Cinnamomi cortex extract, suggesting that it inhibits NO production by suppressing iNOS expression. Additionally, COX-2 induced by LPS was dramatically inhibited by the Cinnamomi cortex extract. Conclusion: These results suggest that 70% methanolic extract of Cinnamomi cortex exerts significant antioxidant activity via inhibiting iNOS and COX-II induction.

How to cite this article:
Chung JW, Kim JJ, Kim SJ. Antioxidative effects of cinnamomi cortex: A potential role of iNOS and COX-II.Phcog Mag 2011;7:314-319

How to cite this URL:
Chung JW, Kim JJ, Kim SJ. Antioxidative effects of cinnamomi cortex: A potential role of iNOS and COX-II. Phcog Mag [serial online] 2011 [cited 2019 Jul 19 ];7:314-319
Available from:

Full Text


Cinnamomi cortex has been widely used as a herbal medicine in Asia and Europe. It has long been used as a medicinal stuff in traditional oriental medicine and folk remedies and is widely used as a material of liquor, tea, or herb medicines. It has been found that it contains cinnamaldehyde, phellandrene, eugenol, and methyleugenol. A variety of pharmacological effects have been suggested: anti-inflammatory action via cyclooxygenase-II, sedative effects, and anti-bacterial activity against Escherichia coli and Pseudomonas aeruginosa are among them. [1],[2],[3] In traditional Chinese medicine, Cinnamomi cortex has been claimed for improving blood circulation. In addition, it has been found that Cinnamomi cortex has the ability to inhibit platelet aggregation via suppressing release of arachidonic acid. [4] Recently, an interesting report has been published that cinnamaldehyde, a main component of Cinnamomi cortex, induces endothelium-dependent and -independent vasorelaxant action on isolated rat aorta. [5]

iNOS is a key enzyme responsible for the production of nitric oxide (NO), and it plays an important role in the oxidative stress and inflammation; it has been suggested that COX-II is also take part in the same processes. In this study, we explored to determine if whether Cinnamomi cortex extracts have antioxidative activities and tested whether iNOS and COX II are involved in anti-oxidative actions exerted by Cinnamomi cortex.

 Materials and Methods

Preparation of plant extracts

Authentic samples of Cinnamomi cortex were purchased from Kyung-Dong Oriental Market in Seoul. They were authenticated by Emeritus Professor Chang-Soo Yok, Department of Oriental Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Korea. Cinnamomi cortex (100 g) was cut into small pieces and extracted with 70% methanol (300 ml) for 3 h, three times. The resulting methanol extract was concentrated by a rotary evaporator and dried by a freeze-dryer.

Reagents and materials

The iNOS and COX-2 antibodies were purchased from Cell Signaling and Santa Cruz Biotechnology Co., respectively. The ECL kit was purchased from Amersham Co. All other reagents were purchased from Sigma Co. Cell culture media were purchased from Gibco Co.

Free radical scavenging activity

Free radical scavenging activity was measured by evaluating the ability to remove 1,1­diphenyl-­2-­picrylhydrazyl (DPPH) under the principle of reduction reactions of DPPH radical solutions in the presence of hydrogen-donating antioxidants. [6] DPPH (Fluka Chemie, Buchs, Switzerland) solutions show an optical density at 515 nm and show a very deep violet color. Once DPPH. has been reduced by antioxidants, the optical density and the degree of color development are reduced. Briefly, Cinnamomi cortex extract was dissolved in 1 ml MeOH, and then was mixed with 1 ml DPPH . solution at room temperature. Then, optical density was measured at 515 nm.

Reducing power

The reducing power was measured using the Oyaizu's method. [7] An aliquot of 2.5 ml of Cinnamomi cortex extract (0.2 M phosphate buffer, pH 6.6) was put into 2.5 ml of potassium ferricyanide (10 mg/ml) solution and subjected to react for 15 min at 30 °C. An aliquot of 2.5 ml of trichloroacetic acid (100 mg/ml) was put into the reactant and mixed up and 2.5 ml of the mixture was again mixed with 2.5 ml of distilled water and 0.5 ml of ferric chloride (1.0 mg/ml) and the optical density was measured at 700 nm.

Cell culture

Murine RAW 264.7 macrophage cells were cultured in Dulbecco's modified Eagle's Medium (Gibco BRL, Grand island, NY) with 10% heat-inactivated fetal bovine serum in 5% humidified CO 2 atmosphere at 37 °C.

Measurement of nitric oxide

The Raw cells were cultured with DMEM and 10% FBS. NO was measured with cell supernatant as nitrite and nitrate. The safe form of nitrite after being reduced to nitrate was measured using the Greiss reagent (Sigma, USA). A total of 2 × 10 6 Raw cells were put into a 6 well plate and washed two times with PBS when the confluence was 80% and then cultured for at least 24 h and the samples were made into the final concentrations of 10, 1.0, 0.1 mg/ml for experiments. Four hours later, lipopolysaccharide (LPS, final concentration 1 mg/ml) was put into all wells except for the well for the control group to stimulate the cells. The amounts of NO generated were measured with the supernatant 18 h later at 540 nm.

Measurement of iNOS and COX-II expression by Western blot analysis

Raw cells were cultured with DMEM and 10% FBS. When the cells reached confluence, the DMEM culture medium was removed and replaced by the EMEM culture medium which is a serum-free culture medium and then the cells were treated with Corni fructus extracts and cultured for 24 h. The cells were washed two times with PBS and scraped into a buffer containing 10 mM Tris-HCl, pH 7.4, 50 mM NaCl, 5 mM EDTA, 30 mM NaF, 0.1 mM Na 3 VO 4 , 1% triton X-100, 0.5% NP-40, 1 μg/ml leupetin, 1 μg/ml aprotinin. Then, the cells were disrupted by passing them through a 1-ml tuberculin syringe five times. The cell lyaste was subjected to centrifugation at 10,000 × g for 10 min and the supernatant was used for western blot analysis. The protein content of the soluble fraction was assessed by the method of Bradford. [8] Protein (50 μg/lane) was electrophoretically separated in 10% polyacrylamide gels containing SDS. Proteins were transferred to nitrocellulose membranes (Schleicher and Schuell), which was carried out for 1 h at 100 V (constant) as described by Towbin et al. The filter papers were preincubated for 1 h at 23°C with PBS containing 0.1% Tween 20 and 5% skim milk and washed with PBS containing 0.1% Tween 20 three times for 10 min each. Followed by the blots were probed with primary antibody directed against iNOS (1:1000), COX-II (1:2000), GAPDH (1:1000) for 2 h at room temperature or overnight at 4 °C diluted in blocking buffer. The blots were then incubated with HRP-conjugated anti-rabbit IgG (1:1000 for iNOS and GAPDH; 1:2000 for COX-II) for 1 h at room temperature and washed with PBS containing Tween 20 three times for 10 min each. The detection of immobilized specific antigens was carried out by ECL (NEN). The images analysed using Image J software.

Component analysis (anthocyanin, phenolics, flavonoids)

Measurement of total phenolics

The total phenolics content was measured using the Folin-Ciocalteau procedure at 725 nm. [9] Gallic acid was used as a standard for phenolic compounds and the phenolic concentration was calculated by using a gallic acid standard calibration curve. The total phenolics content was expressed as the gallic acid equivalent (mg gallic acid/g extract).

Measurement of total flavonoids

The total flavonoids existing was measured using the method of Miliauskas et al, [10] and was expressed as the rutin equivalent (mg rutin acid/g extract) using rutin as a standard flavonoid. One milliliter of the Cinnamomi cortex extract was mixed with aluminum trichloride in ethanol (20 mg/ml) and diluted to 25 ml. After incubation for 40 min at 20 °C, the optical density was measured at 415 nm.

Measurement of total anthocyanin

The total anthocyanin was measured using color reactions. [11] Corni fructus extracts were dissolved in 1 ml of acetate buffer (25 mM, pH 4.5) and the optical density was measured at 520 nm. The content of anthocyanin was expressed as kuromanin equivalent (mg kuromanin/ g extract).

Statistical analysis

All data were expressed as mean ± SEM. Statistical analysis was performed using the GraphPad Prism 5 with one-way ANOVA followed by Turkey's multiple comparison test. P < 0.05 was considered as significant.


DPPH free radicals were decreased by approximately 26% at 0.01 mg/ml of the Cinnamomi cortex extract and about 77% at 0.1 mg/ml as compared to the control. At 1.0 mg/ml, the DPPH free radicals decreased by around 57% [Figure 1]. The Cinnamomi cortex extract also decreased the level of NO by 11%, 15% and 20% at 0.01, 0.1, and 1 mg/ml, respectively [Figure 2]. Regarding reducing power of Cinnamomi cortex extracts, it stimulated the reducing power by 3.1-fold and 13-fold as compared to control, respectively [Figure 3]. Its reducing power appeared almost the same as that of vitamin E. The amount of nitric oxide production markedly increased (2.3-times over basal) when the Raw cells were treated with LPS to activate the macrophages whereas when the cells were pretreated with the Cinnammoi cortex extract, NO production was significantly decreased by 33%, 37%, and 49% in response to 0.01, 0.1, and 1 mg/ml extract, respectively, as compared to the control [Figure 4]. {Figure 1}{Figure 2}{Figure 3}{Figure 4}

To elucidate mechanisms of antioxidant actions by the Cinnamomi cortex extract, expression of iNOS which is a key enzyme for the generation of NO was examined by western blot analysis using a specific iNOS antibody. When LPS was administered to the Raw cells, the expression of iNOS increased by 19-fold over basal. On the other hand, when the cells were pretreated with Cinnamomi cortex extract, iNOS expression levels were markedly decreased by 34%, 77%, and 96% in response to 0.01, 0.1, and 1 mg/ml, respectively [Figure 5]. Cyclooxygenase-2 (COX-2) was also explored to see if it is a target of Cinnamomi cortex extract. When LPS was administered, the expression of the COX-2 enzyme was induced by 6.6-fold over basal. The Cinnamomi cortex extract had little effect on the expression of LPS-induced COX-II at 0.01 mg/ml; however, it was dramatically inhibited by 82% and 100% at 0.1 and 1 mg/ml, respectively [Figure 6].{Figure 5}{Figure 6}

When antioxidant components present in the Cinnamomi cortex extract was analyzed, total phenolics, total flavonoids, and total anthocyanin were determined as 0.36, 38.73, and 24.65 mg/g, respectively [Table 1].{Table 1}


A significant body of evidence has accumulated to indicate that oxidative stress plays an important role in the development of many diseases such as diabetes, Parkinson's disease, cardiovascular diseases, and periodontal diseases. In this study, we have provided evidence that the Cinnamomi cortex extract exerts antioxidative actions via inhibition of iNOS and COX-II induction.

Oxygen free radicals are produced in a large amount by various environmental factors, such as air pollution or smoking, ultraviolet rays, stress, and intensive exercises and they play an essential role in damaging lipid, proteins, and nucleic acid, thereby promoting various kinds of diseases and aging. [12],[13]

The DPPH free radical removing action and nitric oxide scavenging action of the Cinamomi cortex extract are clearly demonstrated in this study. Strikingly, it showed approximately 13 times potent reducing power as compared to control. These results strongly suggest that the Cinnamomi cortex extract has the ability to remove various kinds of free radicals generated due to oxidative stress. In addition, the marked reducing power of the extract will be beneficial in removing toxic peroxides generated by oxidizing reactions.

Wahl et al, [14] proposed that decreasing the levels of nitric oxide in the synovial fluid of patients with chronic temporomandibular diseases could result in reducing pain and tissue damages. Interestingly, it has been suggested that oxidative stress could affect the progress of periodontal diseases and antioxidant substances such as flavonoids or vitamin C could suppress such progresses. [15],[16],[17] Nitric oxide (NO) is a substance that plays an important role in various kinds of inflammatory responses in vivo and it is generated by the iNOS enzyme that is induced by inflammation. Plant extracts have been shown to affect iNOS and COX-II, thereby inducing anti-inflammatory actions. [18],[19],[20],[21] In this study, it has been found that the Cinnamomi cortex extract significantly reduces NO generated by LPS in the Raw cells with dramatic inhibition of iNOS expression. Similarly, COX-II was also affected by the Cinnamomi cortex extract. These results suggest that the anti-oxidative action of the Cinnamomi cortex extract is mediated by the inhibition of the iNOS-NO system as well as COX-II enzyme. Taken together, anti-oxidative actions of the Cinnamomi cortex extract could be useful in the prevention and treatment of various inflammatory diseases including chronic temporomandibular diseases.

Recently, it has been identified that a number of plant extracts containing phenolics, anthocyanin, and flavonoids exert remarkable antioxidative actions. [22],[23],[24] It has been identified that the Cinnamomi cortex extract has diverse components including cinnamaldehyde. The Cinnamomi cortex extract contains significant amounts of phenolics including anthocyanins and flavonoids, suggesting that these components could be major contributors to the iNOS and COX-II inhibitory action of the Cinnamomi cortex extract. However, it will be necessary to isolate the real chemical constituents of Cinnamomi cortex to better understand the mechanism of its anti-oxidative actions.


We propose that the antioxidant activities of the Cinnamomi cortex extract are due to the inhibition of iNOS and COX-II, and scavenging of NO and free radical. This property could be applied to the prevention and treatment of various kinds of diseases triggered by oxidative stress such as temporomandibular joint diseases, periodontal diseases, ulcers, arthritis, hepatitis, and nephritis. In-depth component analyses of the Cinnamomi cortex extract and the identification of active principle(s) will give us insight into the development of new therapeutics having antioxidant actions.


1Chang JS, Chiang LC, Hsu FF, Lin CC. Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro. Am J Chin Med 2004;32:717-25.
2Harada M, Ozaki Y. Pharmacological studies on Chinese cinnamon. I. Central effects of cinnamaldehyde. Yakugaku Zasshi 1972;92:135-40.
3Huss U, Ringbom T, Perera P, Bohlin L, Vasange M. Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod 2002;65:1517-21.
4Takenaga M, Hirai A, Terano T, Tamura Y, Kitagawa H, Yoshida S. In vitro effect of cinnamic aldehyde, a main component of Cinnamomi Cortex, on human platelet aggregation and arachidonic acid metabolism. J Pharmacobiodyn 1987;10:201-8.
5Yanaga A, Goto H, Nakagawa T, Hikiami H, Shibahara N, Shimada Y. Cinnamaldehyde induces endothelium-dependent and -independent vasorelaxant action on isolated rat aorta. Biol Pharm Bull 2006;29:2415-8.
6Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. Lebenson Wiss Technol 1995;28:25-30.
7Oyaizu M. Studies on products of browning reaction: Antioxidative activities of products of browning reaction prepared from glucosamine. Jpn J Nutr 1986;44:307-14.
8Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;722:248-54.
9Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic reagents. Am J Enol Vitic 1965;16:144-58.
10Miliauskasa G, Venskutonis PR, van Beekb TA. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chem 2004;85:231-7.
11Piccolella S, Fiorentino A, Pacifico S, D'Abrosca B, Uzzo P, Monaco P. Antioxidant properties of sour cherries (Prunus cerasus L.): Role of colorless phytochemicals from the methanolic extract of ripe fruits. J Agric Food Chem 2008;56:1928-35.
12Kim BJ, Kim JH, Kim HP, Heo MY. Biological screening of 100 plant extracts for cosmetic use (II): Anti-oxidative activity and free radical scavenging activity. Int J Cosmet Sci 1997;19:299-307.
13Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 2003;106:129-36.
14Wahl SM, McCartney-Francis N, Chang J, Dionne R, Ta L, Orenstein JM. Nitric oxide in experimental joint inflamation. Cells Tissues Organs 2003;176:26-33.
15Tomofuji T, Ekuni D, Irie K, Azuma T, Endo Y, Tamaki N, et al. Preventive effects of a cocoa-enriched diet on gingival oxidative stress in experimental periodontitis. J Periodontol 2009;80:1799-808.
16Sanbe T, Tomofuji T, Ekuni D, Azuma T, Tamaki N, Yamamoto T. Oral administration of vitamin C prevents alveolar bone resorption induced by high dietary cholesterol in rats. J Periodontol 2007;78:2165-70.
17Canakçi CF, Tatar A, Canakç IV, Cicek Y, Oztas S, Orbak R. New evidence of premature oxidative DNA damage: Mitochondrial DNA deletion in gingival tissue of patients with periodontitis. J Periodontol 2006;77:1894-900.
18Sriramaneni RN, Omar AZ, Ibrahim SM, Amirin S, Zaini AM. Vasorelaxant effect of diterpenoid lactones from Andrographis paniculata chloroform extract on rat aortic rings. Pharmacogn Res 2010;2:242-6.
19Handunnetti SM, Kumara RR, Deraniyagala SA, Ratnasooriya WD. Anti-inflammatory activity of i0 xora coccinea methanolic leaf extract. Pharmacogn Res 2009;1:80-90.
20Gambhire MN, Wankhede SS, Juvekar AR. Antiinflammatory activity of aqueous extract of Barleria cristata leaves. J Young Pharm 2009;1:220-4.
21Kumar D, Kumar S, Singh J, Narender, Rashmi, Vashistha BD, et al. Free radical scavenging and analgesic activities of Cucumis sativus L. fruit extract. J Young Pharm 2010;2:365-8.
22Sim KS, Sri Nurestri AM, Norhanom AW. Phenolic content and antioxidant activity of Pereskia grandifolia Haw. (Cactaceae) extracts. Pharmacogn Mag 2010;6:248-54.
23Ozgen M, Scheerens JC, Reese RN, Miller RA. Total phenolic, anthocyanin contents and antioxidant capacity of selected elderberry (Sambucus canadensis L.) accessions. Pharmacogn Mag 2010;6:198-203.
24Tian S, Shi Y, Zhou X, Ge L, Upur H. Total polyphenolic (flavonoids) content and antioxidant capacity of different Ziziphora clinopodioides Lam. Extracts. Pharmacogn Mag 2011;7:65-8.